Background {#Sec1}
==========

Melioidosis is caused by a gram-negative, motile, non-spore forming facultative anaerobic bacillus known as *Burkholderia pseudomallei.* The organism is found in soil and surface water and is widely distributed in Southeast Asia, especially in northeast Thailand and northern Australia \[[@CR1]\].

Melioidosis presents with broad spectrums of clinical presentations and organ involvement. However, there are few case reports of ocular involvement in melioidosis, and most of these are single-case report or small case series.

In northeast Thailand, there are around 2000 culture-positive melioidosis cases per year \[[@CR2]\]. Khon Kaen, one of the largest cities in northeast Thailand, has been called "the capital of melioidosis" due to the high prevalence of the disease in the region. Ocular involvement in these cases has not been investigated. The primary objective of this study was to estimate the prevalence and investigate ocular manifestations of melioidosis in Khon Kaen. Management and visual outcomes in these patients were also reviewed.

Results {#Sec3}
=======

We identified 16 cases of ocular involvement, 13 out of the 1270 melioidosis cases admitted to Srinagarind Hospital (prevalence 1.02%; 95% confidence interval from 0.58 to 1.76%) and three out of the 607 admitted cases at Khon Kaen Hospital (prevalence 0.49%; 95% confidence interval from 0.10 to 1.51%). Overall, the estimated prevalence of ocular involvement in cases of melioidosis was from 0.49 to 1.02% (Table [1](#Tab1){ref-type="table"}).Table 1Data collection and prevalence (95%CI) calculationTertiary hospitalSrinagarind University HospitalKhon Kaen Provincial HospitalTotal from all dataTotal from 2012 to 2016DateJanuary 1993 to April 2016January 2012 to April 2016January 1993 to April 2016January 2012 to April 2016Length23 years and 4 months4 years and 4 months23 years and 4 months4 years and 4 monthsTotal melioidosis (cases)12706071877859Total ocular involvement (cases)133168Prevalence\
(95% CI)1.02% (0.58, 1.76%)0.49% (0.10, 0.51%)0.85% (0.51, 1.39%)0.93% (0.44, 1.86%)

Of those 16 cases, there were 8 with positive cultures. In the remaining eight cases, melioidosis was implied from the high titer for melioidosis in the bloodstream. Clinical descriptions of all cases are summarized in Table [2](#Tab2){ref-type="table"}.Table 2Clinical descriptions of all casesYearAgeSexOccupationSymptomLateralityInitial VAOcular positive findingOcular diagnosisRisk factorType of melioidosisPrimary organAssociated symptomsInvestigationsTreatmentsOutcomes200770FNoneProgressive painful proptosis with fever 10 days, S/P IV cloxacillin at provincial hospital (onset = 10 days)ODNo LPComplete ptosis, mark eyelid swelling, IOP 21/13, marked chemosis, clear cornea, no C/F, positive RAPD, EOM 0% all direction, pale disc with choroidal foldOrbital cellulitisHistory of eye scratching with dirty handDisseminatedEyeAcute sphenoidal sinusitis, meningitis, septic arthritis, melioidosis septicemiaHemoculture: *B. pseudomellei*, LP: eosinophilic meningitis, MRI orbit: right orbital cellulitis with extraconal abscess latero-superior aspectFESS, I&D, IV ceftazidime then oral bactrim, tarsorhaphyVA no LP, limit EOM 90% at lateral gaze OD, other EOM are full, normal anterior segment, pale disc, attenuated vessel (No LP at initial)200764MFarmerProgressive proptosis 10 days PTA, S/P IV ceftazidime, IV clindamycin at provincial hospitalOSCF 2 ftLid swelling, proptosis, chemosis, clear cornea, no C/F, positive RAPD, EOM 10% all directionOrbital cellulitisDM without DR, CKDDisseminatedEyePansinusitis, subcutaneous abscess at inferolateral of the eyeHemoculture: *B. pseudomellei*, pus culture: *B. pseudomellei*. CT orbit: pansinusitis with severe orbital cellulitisI&D, FESS, IV ceftazidime then oral bactrim, topical antibioticVA 6/24, VA with pinhole 6/12, less chemosis, less proptosis, normal anterior segment, EOM limit at downgaze(onset = 10 days)(improve)200861MFarmerProgressive painful visual loss 2 weeksOSNo LPGeneralized bedewing cornea, hypopyon 2-mm, shallow AC, C/F 3+/2+, positive RRAPD, EOM 50% all direction, B scan: generalized vitreous opacity, intra-op findings: dense vitreous abscess, subretinal abscess rupture to vitreousPanophthalmitisDM without DR, CKDLocalizedEyeHemoculture: no growth, melioid titer 1:5122, CT orbit: swelling of periorbital tissuePPV, ECCE, topical vancomycin, topical ceftazidime, oral bactrimVA no LP, conjunctival less chemosis, AC deep with plasmoid and hyphema, no record about posterior segment(onset = 2 weeks)(No LP at initial)200851FTeacherFever with dyspnea 12 days PTA, left eye inflammation was found during admissionOSHM, good PJCorneal bedewing, C/F 4+/4+, positive RRAPD, intra-op findings: attenuated vessels, subretinal gliosis, shallow RDEndogenous endopthalmitisDM without DRDisseminatedHematogenousPulmonary edemaHemoculture: no growth, melioid titer 1:5122, MRI orbit: preseptal cellulitisPPV with silicone oil, ECCE, IV ceftazidime then oral bactrim, topical vancomycin, topical ceftazidimeVA HM poor PJ, AC deep with plasmoid, attach retina(onset = NA)(stable)200939FFarmerEye pain with fever 2 weeksOD6/24Marked eyelid swelling and erythema, fluctuation, no discharge, clear cornea, no C/F, negative RAPD, normal posterior segmentPreseptal cellulitisDM without DRMultifocalEyePneumonia, subcutaneous abscess at right thighPus culture: *B. pseudomellei*, melioid titer 1/640, hemoculture: NG, CT orbit: preseptal cellulitisI&D upper eyelid, I&D right thigh, oral bactrimVA 6/9, normal anterior and posterior segment(onset = 2 weeks)(improve)201146MLaborFever with constitutional symptoms 2 weeks then visual loss 3 daysOSCF 2 ftConjunctival chemosis, corneal stromal edema, hypopyon, hyphema, C/F 4+/2+, retinal infiltrationEndogenous endophthalmitisDM without DRMultifocalHematogenousLiver abscesses, splenic abscessHemoculture: no growth, melioid titer 1:5122, CT abdomen: multiple liver abscesses, splenic abscessIV ceftazidime then oral bactrimVA 3/60, VA with pinhole 4/60, contracted hypopyon, vitreous opacity grade 1(onset = 3 days)(improve)201143FFarmerPainful proptosis 8 days PTA, S/P IV antibiotic at provincial hospital then alteration of consciousness 1 dayOSNot done due to alteration of consciousnessNecrotizing fasciitis at left upper eyelid size 1 × 8 cm, purulent discharge, ciliary injection, clear cornea, no C/F, clear vitreousOrbital cellulitis, necrotizing fasciitisFirst dx DM without DRDisseminatedEyePansinusitis, melioidosis septic shockHemoculture: *B. pseudomellei*, pus culture: *B. pseudomellei*, CT orbit: orbital abscess at the superomedial wall of orbit, medial rectus muscle, lateral rectus muscleDebridement of necrotic wound, IV ceftazidime then oral bactrimGood wound, less swelling, no record about VA(onset = 8 days)(NA)201146MLaborPainless visual loss 1 month PTA then painful proptosis 2 daysOSLP, poor PJIOP 32, bedewing cornea, hypopyon with plasmoid in AC, negative RAPD, intra-op finding: subretinal abscessEndogenous endopthalmitisDM without DRMultifocalEye, liverLiver abscessHemoculture: NG, melioid titer 1:640PPV with silicone oil, oral bactrimPainful red eye 1 week after discharge, VA no LP, IOP 40, shallow AC, iris bombe end up with enucleation, intra-op finding: flank pus in the vitreous cavity(onset = 1 month)(enucleated)201263MFarmerPainful proptosis 2 weeksOD20/200Marked eyelid swelling, no discharge, conjunctival injection, keratic precipitates at the cornea, peripheral synechiae 360 degrees, C/F 4+/2+, vitreous opacity grade 4Panuveitis, preseptal cellulitisMDS, leukemiaDisseminatedEyeSpondylodiscitis, epidural and paravertebral abscessHemoculture: no growth, melioid titer 1: 5120IV ceftazidime, 1% prednisolone acetate eye drop RE qidVA 20/200, peripheral synechiae 360 degrees, vitreous opacity grade 1(onset = 2 weeks)(stable)201254MFarmerFever with left side headache 1 week PTA then left facial edema 5 days PTA then painful proptosis 3 daysOSNo LPMarked eyelid swelling, erythema and tender, copious pus and discharge, marked chemosis, clear cornea, no C/F, positive RRAPD, B scan: vitreous opacity, intra-op finding: pus 1 ml in the vitreous cavity, flame shape hemorrhage, disc swelling, venous congestion, drusenOrbital cellulitisDM without DRDisseminatedMaxillary sinusMaxillary sinusitis, melioidosis septicemiaHemoculture: *B. pseudomellei*, pus culture: *B. pseudomellei*, CT orbit: maxillary sinusitisI&D, orbital decompression, IV ceftazidime then oral bactrimVA no LP, less swelling periorbital area, conjunctival chemosis, normal anterior segment, limit EOM all direction, fundus: disc swelling, flame shape hemorrhage(onset = 1 week)(No LP at initial)201265MHouse keeperFever with chill 3 days PTA then alteration of consciousness 1 day, then right upper eyelid swelling at the emergency departmentOD6/6Upper eyelid swelling, erythema and tender, conjunctival chemosis, clear cornea, no C/F, negative RAPD, normal posterior segment, full EOMPreseptal cellulitisDM without DRDisseminatedHematogenous--Hemoculture: no growth, melioid titer 1:640IV ceftazidime then oral azithromycinVA 6/6, no lid swelling, mild erythema, normal anterior and posterior segment(onset = \< 1 day)(improve)201357MThai massagerPain at the left temporal area 3 week PTA then painful proptosis 3 days, S/P IV antibiotic at primary care hospital, S/P I&D temporal space abscess at provincial hospitalOS20/200Proptosis, chemosis, clear cornea, no C/F, negative RAPD, EOM 10-20% all direction, fundus: macular striae, mild pale discOrbital cellulitisDM without DRLocalizedTemporal space abscessTemporal space abscess, subperiosteal abscessPus culture: *B. pseudomellei*, hemoculture: NG, CT orbit: left panophthalmitis with subperiosteal abscessI&D temporal space abscess, lateral and medial orbitotomy, I&D orbital abscess, IV ceftazidime then oral bactrimVA 6/9, no sign of inflammation, residual ptosis, normal anterior segment, no record about posterior segment(onset = 3 weeks)(improve)201442MFarmerRight eye contact with wood particle 10 days PTA then drop of breast milk into the eye 4 days PTA then acute visual loss 2 days, S/P IVT vancomycin, ceftazidime at provincial hospitalODHM at provincial hospital then no LPMultiple keratic precipitates at the cornea, C/F 4+/4+, positive RAPD, vitreous opacity grade 4, B scan: loculated vitreous haze, membrane-like lesion attach to disc, moderate to high spike, intra-op finding: yellow pus with blood clotEndogenous endophthalmitisCKD, chronic alcoholism, wood particle contact, breast milk instillationMultifocalEyeSplenic abscessGram stain from pus: gram-negative rod safety pin, pus culture: no growth, hemoculture: no growth, melioid titer 1:5122, ultrasound abdomen: splenic abscessEnucleation, IV ceftazidime then oral bactrimGood enucleation wound(onset = 10 days)(enucleated)201445MOfficerProptosis 4 days PTA, S/P FESS, orbital decompression at private hospitalOSCFMarked eyelid swelling, fluctuation, chemosis, limit EOM at upper and lateral gaze, clear cornea, no C/F, negative RAPD, normal posterior segment, intra-op finding: loculated abscess at left upper eyelid 5 mlOrbital cellulitisDM without DRMultifocalSinusAbscess at right legPus culture from the eye: *B. pseudomellei*, pus culture from the right leg: *B. pseudomellei*, hemoculture: no growth, ultrasound abdomen: no liver or splenic abscessI&D, IV ceftazidime then oral bactrimLess swelling, less chemosis, normal anterior segment, EOM improve, no record of VA and posterior segment(onset = 4 days)(NA)201550MFarmerLow-grade fever 2 weeks PTA, right eye pain 9 days PTA, painful proptosis with visual loss 7 days PTA, S/P IV ceftazidime, IV metronidazole at provincial hospital, progressive proptosis in this admissionODHMProptosis, marked chemosis, AC deep with C/F 4+/3+, positive RAPD, peripheral synechiae, vitreous opacity grade 4, EOM minimal limit all direction, B scan: vitreous opacity, subretinal abscess, intra-op finding: yellow pus 0.2 mlPanopthalmitis--DisseminatedHematogenousLiver abscess, ethmoid sinusitisHemoculture: no growth, melioid titer 1:5122, vitreous culture: no growthPPV, IV ceftazidimeNo LP, normal globe contour, no record about anterior and posterior segment(onset = 9 days)(worse)201545MFarmerPainful proptosis with fever 2 weeks, S/P IV antibiotic at primary care hospitalOD1/60 at primary care hospital then LPMarked eyelid and periorbital area swelling, vesicle at medial canthus, marked bloody chemosis, clear cornea, no C/F, positive RAPD, EOM 0% all direction, necrotic skin at forehead 2 × 3 cmOrbital cellulitis, Necrotizing fasciitisDM without DR, psoriasis, chronic alcoholismDisseminatedEyeSinusitis, septic arthritis, splenic abscess, septic shockHemoculture: *B. pseudomellei* x II, pus culture from the eye: *B. pseudomellei*, pus culture from the right knee: *B. pseudomellei*I&D, FESS, skin debridement, IV ceftazidimeVA no LP, chemosis, normal anterior segment, RAPD positive, no record of posterior segment(onset = 2 weeks)(worse)

Baseline characteristics of the patients were comparable to general melioidosis patients. The male to female ratio was 3 to 1 with a median age of 50.5 years old (39--70). The most common occupation was farmer (nine cases, 56%). Most patients had underlying diseases (14 cases, 88%), of which diabetes mellitus was the most common (12 cases, 75%). Ocular involvement was part of dissemination in nine cases (56%), which were classified as disseminated septicemic melioidosis.

The majority of ocular melioidosis patients (10 cases, 63%) presented with eye symptoms. Interestingly, the other six cases initially presented with fever or a headache. Out of the 15 cases for which there were records of visual acuity, 11 (73%) presented with blindness. The ocular manifestations of melioidosis were classified as orbital cellulitis (seven cases, 44%), preseptal cellulitis (two cases, 13%), endophthalmitis (four cases, 25%), panophthalmitis (two cases, 13%), and panuveitis (one case, 6%).

In most cases, the definitive management was surgery (13 cases, 81%) including incision and drainage, debridement (eight cases, 62%), pars plana vitrectomy (three cases, 23%), and enucleation (two, 15%). There were only three cases (19%) in which the patients were able to be treated without surgery.

Despite adequate surgical intervention, the visual outcomes of ocular melioidosis were disappointing. Out of the 14 cases for which there were records of final visual acuity, nine (64%) patients ended up legally blind. Three of these patients (20%) presented with no light perception at the beginning, two had to be enucleated, two (14%) were stable, and two (14%) had progressive loss of vision. Patients had improved vision after treatment in only five cases (36%).

Discussion {#Sec4}
==========

To our knowledge, this is the first and largest case series of ocular involvement in melioidosis. A comprehensive literature review revealed only 14 cases from 12 reports \[[@CR3]--[@CR14]\], including 7 cases of orbital cellulitis (50%), 3 cases of endophthalmitis (21%), 3 cases of corneal ulcer (21%), and 1 case of acute dacryocystitis (7%). Most of the reports were single-case reports, and the largest one had only three cases.

In Thailand, especially in the northeast, there has been an increase in the reported cases of melioidosis. This is likely due to increasing awareness of the condition and increased sensitivity of the technology used to detect the organism. The mortality rate in these areas is around 40%. It is the third highest cause of mortality after acquired immune deficiency syndrome and tuberculosis \[[@CR2]\]. Although ocular involvement in melioidosis is rare, the effects on patients' vision are devastating. Most patients with this condition ended up becoming legally blind. In our series of 16 cases, there were only 5 (36%) in which patients had improved vision after treatment.

We suspect that the number of ocular melioidosis cases might be underestimated. Most of the melioidosis patients admitted to the hospital had disseminated septicemic melioidosis and were treated for life-threatening symptoms. Mild ocular symptoms might be easily overlooked, and ophthalmologists were not consulted in all cases.

The prevalence of ocular melioidosis in Srinagarind Hospital (1.02%) was about twice that in Khon Kaen Hospital (0.49%). The discrepancy might be due to the differences between the two hospitals. Srinagarind Hospital is the largest university hospital in northeast Thailand, and many severe cases of systemic melioidosis are referred to Srinagarind Hospital. Since more organs are affected in severe disseminated melioidosis, ocular involvement is more likely in these cases.

We suspect that the recent prevalence of ocular melioidosis in Srinagarind Hospital might be much higher than what we have found. From 2007 to April 2016, there were 264 cases of melioidosis at Srinagarind Hospital, of which 13 had ocular involvement. According to this finding, the prevalence during this time interval was as high as 4.9% (95% confidence interval from 2.82 to 8.32%).

This study led to some interesting findings. Ten patients (63%) presented with eye symptoms, which later resulted in systemic spreading. On the other hand, there were six patients (38%) whose first symptoms were not eye symptoms; four patients (25%) presented with fever and two (13%) presented with a headache. In most cases, diabetes mellitus was the underlying disease (12 cases, 75%), but none of the patients in those cases had diabetic retinopathy.

Interestingly, we found that most cases of ocular melioidosis were classified as disseminated septicemic melioidosis (nine cases, 56%) which means that there was a bloodstream infection. This is unlike other gram-positive organisms, which usually cause orbital cellulitis and commonly result in a negative hemoculture. The explanation for this finding may be attributable to the nature of *Bulkholderia pseudomallei* infection, which generally presents with bloodstream infection.

In our study, orbital cellulitis was the most common manifestation (seven cases, 44%). Usually, orbital cellulitis is caused by gram-positive organisms and can be cured only by intravenous antibiotics, unlike orbital cellulitis caused by melioidosis. All of these patients ended up undergoing surgical intervention (100%). The abscess-forming activity of *Burkholderia pseudomallei* may be the reason why intravenous antibiotics alone did not work to treat the condition.

Moreover, there were two cases (29%) of orbital cellulitis that progressed to necrotizing fasciitis, which is uncommon in other types of bacterial orbital cellulitis. This is similar to the results of a previous case report by Saonanon P \[[@CR13]\]. Unfortunately, all of our patients (100%) with necrotizing fasciitis subsequently developed septic shock. Early suspicion and prompt surgical debridement may improve mortality in these patients.

We also found that even if systemic ceftazidime was used, the occurrence of endogenous endophthalmitis caused by melioidosis was not preventable, as stated in a previous report \[[@CR10]\]. Most of the cases diagnosed as endophthalmitis and panophthalmitis required surgical intervention (five out of six cases, 83%), including pars plana vitrectomy (three out of five cases, 60%) and enucleation (two out of five cases, 40%).

Two cases (50%) of endophthalmitis were enucleated. The first case, from 2011, had a delayed presentation. The patient had experienced loss of vision for 1 month prior to admission, which was the longest onset in any of the cases. In the second case, from 2014, the patient exhibited two risk factors for the condition, including wood particle contact and breast milk instillation into the eye, as a result of local traditional treatment practices.

There were three cases that were cured without any surgical intervention. In one case, this was due to the patient seeking early treatment for endogenous endophthalmitis. The other two patients had diagnoses that did not require an operation (namely, panuveitis and preseptal cellulitis).

Conclusions {#Sec5}
===========

In summary, ocular involvement in melioidosis was rare, but the outcomes were devastating. The most common ocular involvements were orbital cellulitis and endophthalmitis. The morbidity in these cases was high, so it is critical to employ a high index of suspicion. Ocular melioidosis should be considered when the ocular infection does not respond to conventional antibiotic therapy, especially in hyperendemic regions for melioidosis. Early consultation with an ophthalmologist and prompt surgical intervention may significantly improve the final visual outcomes, as well as mortality rates.

Methods {#Sec2}
=======

We retrospectively reviewed all admitted cases of melioidosis with ocular involvement from two tertiary hospitals in Khon Kaen using electronic databases. The first is Srinagarind Hospital, which is a university hospital. We searched the hospital's electronic database for cases of this condition from January 1993 to April 2016 (23 years and 4 months). The second is Khon Kaen Hospital, which is a provincial hospital. We searched the hospital's electronic database for cases that presented between January 2012 and April 2016 (4 years and 4 months). The data were retrieved using the ICD10 code for melioidosis (all A24 codes) and all diseases of the eye and adnexa (code H00 to H59).

This manuscript adheres to the guidelines and principles laid out in the Declaration of Helsinki. Institutional review board (IRB) approval was obtained from the Khon Kaen University and Khon Kaen Hospital, Thailand. The clinical trial was registered in Thai Clinical Trials Registry (study ID: TCTR20160818004).

We only included cases in which there were positive cultures for melioidosis or high blood titer according to indirect hemagglutination (IHA). The cutoff point for positive antibody titers has been determined to be 1:160 in endemic areas \[[@CR15]\]. Irrelevant ocular diagnoses, such as cataracts, glaucoma, diabetic retinopathy, or other underlying eye diseases, were excluded. The prevalence and 95% confidence intervals (95% CI) were calculated using the modified Wald method. Other results were summarized as proportions and percentages.
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